Shopping Cart 0
Cart Subtotal
USD 0

AbGenomics International Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

AbGenomics International Inc (AbGenomics) is a clinical-stage biopharmaceutical company that develops therapeutics for inflammatory or autoimmune diseases and cancers. The company offers products such as pipeline products, monoclonal antibody products, therapeutic products, neihulizumab, bio-therapeutics, and preclinical biobetter and biosuperior antibody-drug conjugates (ADCs). It pipeline products include neihulizumab AbGn-168H, leiolizumab AbGn-168H2, AbGn-107 and AbGn-207. AbGenomics' thearupitic areas comprise psoriasis, gastric and pancreatic cancer, breast cancer, immune-mediated inflammatory diseases, lung and ovarian cancers, and lung and colorectal cancers, among others. The company operates its offices in the US and Taiwan. AbGenomics is headquartered in Los Altos, California, the US.

AbGenomics International Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

AbGenomics International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

AbGenomics International Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

AbGenomics International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

AbGenomics International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

AbGenomics International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

AbGenomics International Inc, Pharmaceuticals & Healthcare, Deal Details 10

Venture Financing 10

AbGenomics Raises USD16 Million in Venture Financing 10

AbGenomics International Raises USD13 Million in Venture Financing 11

AbGenomics International Raises USD 9.6 Million In Venture Financing 12

AbGenomics International Raises USD 11 Million In Venture Financing 13

AbGenomics International Inc-Key Competitors 14

AbGenomics International Inc-Key Employees 15

AbGenomics International Inc-Locations And Subsidiaries 16

Head Office 16

Other Locations & Subsidiaries 16

Recent Developments 17

Product Approvals 17

Mar 20, 2018: FDA Grants AbGenomics AbGn-168H (Neihulizumab) Orphan Drug Designation 17

Appendix 18

Methodology 18

About GlobalData 18

Contact Us 18

Disclaimer 18


List Of Figure

List of Figures

AbGenomics International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

AbGenomics International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

AbGenomics International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

AbGenomics International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

AbGenomics International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

AbGenomics International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

AbGenomics International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

AbGenomics International Inc, Pharmaceuticals & Healthcare, Key Facts 2

AbGenomics International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

AbGenomics International Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

AbGenomics International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

AbGenomics International Inc, Deals By Therapy Area, 2012 to YTD 2018 8

AbGenomics International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

AbGenomics Raises USD16 Million in Venture Financing 10

AbGenomics International Raises USD13 Million in Venture Financing 11

AbGenomics International Raises USD 9.6 Million In Venture Financing 12

AbGenomics International Raises USD 11 Million In Venture Financing 13

AbGenomics International Inc, Key Competitors 14

AbGenomics International Inc, Key Employees 15

AbGenomics International Inc, Other Locations 16

AbGenomics International Inc, Subsidiaries 16

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

AbGenomics International Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

AbGenomics International Inc (AbGenomics) is a clinical-stage biopharmaceutical company that develops therapeutics for inflammatory or autoimmune diseases and cancers. The company offers products such as pipeline products, monoclonal antibody products, therapeutic products, neihulizumab, bio-therapeutics, and preclinical biobetter and biosuperior antibody-drug conjugates (ADCs). It pipeline products include neihulizumab AbGn-168H, leiolizumab AbGn-168H2, AbGn-107 and AbGn-207. AbGenomics' thearupitic areas comprise psoriasis, gastric and pancreatic cancer, breast cancer, immune-mediated inflammatory diseases, lung and ovarian cancers, and lung and colorectal cancers, among others. The company operates its offices in the US and Taiwan. AbGenomics is headquartered in Los Altos, California, the US.

AbGenomics International Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

AbGenomics International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

AbGenomics International Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

AbGenomics International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

AbGenomics International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

AbGenomics International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

AbGenomics International Inc, Pharmaceuticals & Healthcare, Deal Details 10

Venture Financing 10

AbGenomics Raises USD16 Million in Venture Financing 10

AbGenomics International Raises USD13 Million in Venture Financing 11

AbGenomics International Raises USD 9.6 Million In Venture Financing 12

AbGenomics International Raises USD 11 Million In Venture Financing 13

AbGenomics International Inc-Key Competitors 14

AbGenomics International Inc-Key Employees 15

AbGenomics International Inc-Locations And Subsidiaries 16

Head Office 16

Other Locations & Subsidiaries 16

Recent Developments 17

Product Approvals 17

Mar 20, 2018: FDA Grants AbGenomics AbGn-168H (Neihulizumab) Orphan Drug Designation 17

Appendix 18

Methodology 18

About GlobalData 18

Contact Us 18

Disclaimer 18


List Of Figure

List of Figures

AbGenomics International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

AbGenomics International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

AbGenomics International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

AbGenomics International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

AbGenomics International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

AbGenomics International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

AbGenomics International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

AbGenomics International Inc, Pharmaceuticals & Healthcare, Key Facts 2

AbGenomics International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

AbGenomics International Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

AbGenomics International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

AbGenomics International Inc, Deals By Therapy Area, 2012 to YTD 2018 8

AbGenomics International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

AbGenomics Raises USD16 Million in Venture Financing 10

AbGenomics International Raises USD13 Million in Venture Financing 11

AbGenomics International Raises USD 9.6 Million In Venture Financing 12

AbGenomics International Raises USD 11 Million In Venture Financing 13

AbGenomics International Inc, Key Competitors 14

AbGenomics International Inc, Key Employees 15

AbGenomics International Inc, Other Locations 16

AbGenomics International Inc, Subsidiaries 16

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

AbGenomics International Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.